Latest News

In recent days, Builders FirstSource received renewed attention from Wall Street as 19 covering analysts maintained a consensus ‘Buy’ rating on the company. This broad analyst agreement underscores how professional sentiment can itself become a factor in investor behavior, even without new operational developments from the business. We’ll now examine how this broad analyst support could influence Builders FirstSource’s existing investment narrative around digital investment, consolidation,...

Recent performance context NMI Holdings (NMIH) has drawn attention after recent trading, with the share price closing at $39.88 and short-term returns mixed, including a one-day decline alongside a gain over the past month. See our latest analysis for NMI Holdings. While the 1 day share price return of a 1.21% decline and a softer 7 day move suggest momentum has cooled recently, the 30 day and 90 day share price returns of 6.92% and 11.30% respectively sit alongside a 1 year total shareholder...

If you are wondering whether Semiconductor Manufacturing International is attractively priced right now, you are not alone. This article will walk through what the current share price may imply about its value. The stock last closed at HK$74.95, with returns of 4.9% over 7 days, 8.9% over 30 days, a 0.2% decline year to date, and gains of 138.3% over 1 year, 337.3% over 3 years and 166.3% over 5 years. These moves sit against a backdrop of ongoing attention on global chip supply, sector...

Insiders who bought Cauldron Energy Limited ( ASX:CXU ) stock in the last 12 months were richly rewarded last week. The...

If you are wondering whether Mosaic's current share price reflects its true worth, this article walks through what the numbers are actually saying about value. Mosaic's share price recently closed at US$25.30, with returns of 5.0% over the last 7 days, 7.0% over the last 30 days, 1.1% year to date, 5.7% over 1 year, and a 39.0% decline over 3 years. Together, these figures give a mixed picture of recent momentum and risk. Recent news around Mosaic has focused on its role in fertilizer...

In early January 2026, Equitable Holdings drew fresh attention as Mizuho Securities initiated bullish analyst coverage, highlighting the company’s broad life insurance offering and positioning it as a leading financial pure play, while new leadership changes were announced at subsidiary AllianceBernstein and Equitable released a Gen X retirement planning study. The combination of strong analyst interest in Equitable’s life insurance focus and its insights into Gen X retirement planning...

If you are wondering whether Arm Holdings at US$115.68 is priced for its story or its fundamentals, you are not alone. The stock has had a mixed run lately, with a 5.8% gain over the last 7 days, a 17.2% decline over the last 30 days, a 0.8% return year to date and a 20.3% decline over the last year. Recent commentary around Arm has focused on its role in the broader semiconductor and chip design space, as investors weigh how its licensing model fits into long term trends. Market discussions...

In recent weeks, Banco Santander withdrew certain 60% loan-to-value UK mortgage products for first-time buyers borrowing under £250,000, as part of a broader repricing after the Bank of England held rates and markets signalled limited further mortgage rate falls. The shift highlights how Santander is prioritizing higher loan-to-value segments, offering first-time buyers 85% and above LTV deals starting around 4.06% for two-year fixes and 4.19% for five-year terms, which may reshape its UK...

Citigroup (C) is back in focus after years of restructuring, with investors reacting to cleaner operations, divestitures such as its Russian unit, and a stronger capital and shareholder return story. See our latest analysis for Citigroup. Recent moves, including the planned exit from Russia and new senior hires in APAC investment banking, have come alongside strong momentum, with a 30 day share price return of 11.43% and a 1 year total shareholder return of 70.27%, suggesting sentiment has...

Teva Pharmaceutical Industries recently reported third-quarter 2025 earnings that exceeded analyst expectations, advanced its pipeline with a U.S. FDA New Drug Application for an olanzapine long-acting injectable for schizophrenia, and secured European Commission approval to market denosumab biosimilars. Alongside these regulatory milestones, Teva’s upcoming CEO presentation at the J.P. Morgan Healthcare Conference underscores its push toward becoming an innovative biopharmaceutical company...

Analyst attention and AI focus put monday.com in the spotlight Recent analyst commentary on monday.com (MNDY), centered on its AI monetization plans and expanding product lineup, has pushed the stock back onto many investors’ watchlists as they reassess the business. See our latest analysis for monday.com. Despite renewed interest, monday.com’s 1 year total shareholder return of 34.05% and 90 day share price return of a 21.33% decline suggest momentum has cooled recently, even as fresh AI...

In early January 2026, TTM Technologies reported revenue rising 22.1% year on year and earnings per share beating analyst expectations, while management also attended the Needham Growth Conference and a director sold 16,800 shares as disclosed in SEC filings. The combination of a strong earnings beat and active investor engagement has prompted many market participants to reassess TTM’s business momentum and outlook. We’ll now examine how TTM’s stronger‑than‑expected earnings performance may...

Why this VANFLYTA agreement matters for Daiichi Sankyo Company (TSE:4568) Daiichi Sankyo Company (TSE:4568) drew investor attention after signing an exclusive license and supply agreement with GENESIS Pharma to distribute and commercialize VANFLYTA across 13 Central and Eastern European markets. The deal extends access to quizartinib for adult patients with newly diagnosed FLT3 ITD positive acute myeloid leukemia, using GENESIS Pharma’s regional reach, while Daiichi Sankyo retains...

If you are wondering whether Cleveland-Cliffs at around US$12.04 is a bargain or a value trap, you are in the right place to size up what the current price actually reflects. The stock has had a mixed run, with a 9.3% decline over the last 7 days and a 2.7% decline over 30 days, yet it still shows a 23.5% return over 1 year and longer term 3 year and 5 year returns of 37.4% and 32.3% declines. Recent attention on Cleveland-Cliffs has centered on its position in the US steel and mining...

If you are wondering whether Weyerhaeuser’s share price really reflects what the business is worth, you are not alone. This article is built to help you answer that question with numbers. Over the last week the stock returned a 2.2% decline, compared with a 4.0% gain over the past 30 days and a 2.6% decline year to date. The 1 year, 3 year and 5 year returns are a 13.5% decline, 18.7% decline and 11.8% decline respectively. Recent coverage around Weyerhaeuser has focused on ongoing interest...

Supportive analyst commentary has put fresh attention on DENTSPLY SIRONA (XRAY) after Barrington Research reiterated an upbeat rating tied to expectations for dental anesthesia market growth and rising procedure volumes, despite recent earnings and guidance pressure. See our latest analysis for DENTSPLY SIRONA. The recent analyst commentary comes after a sharp 7 day share price return of 8.22% and a 30 day share price return of 11.44%. However, the 1 year total shareholder return of negative...

Sony Group (TSE:6758) has completed a share buyback tranche, repurchasing 7,128,800 shares for ¥30,343.82 million, while fresh debate builds around the long term prospects of its PlayStation console business and recent acquisitions. See our latest analysis for Sony Group. Despite the recent buyback and noise around the PlayStation division and past acquisitions, Sony Group’s 1-month share price return of an 8.73% decline and 90-day share price return of an 11.90% decline contrast with a...

If you have been wondering whether UWM Holdings at around US$4.63 is a bargain or a value trap, you are not alone, and the answer depends on how you look at its fundamentals and price together. The stock has had a mixed run, with a 5.7% return over the last 7 days, a 17.9% decline over 30 days, a 5.0% gain year to date, and an 11.8% decline over the last year, while the 3 year return sits at 48.4% and the 5 year return at a 47.2% decline. Recent coverage around UWM Holdings has focused on...

If you are wondering whether RTX is fairly priced after its recent run, this review will walk through what the numbers currently say about its valuation. Over the last week RTX returned 1.3%, over the past month it returned 8.3%, while the year to date return is a 0.8% decline and the 1 year return is 63.2%, with a very large 5 year gain of 195.5% that may have reshaped expectations. Recent attention on RTX has focused on its role as a major aerospace and defense contractor, as investors...

Appen Limited ( ASX:APX ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...

In recent days, Zoetis has been cited as a key player in veterinary infectious disease diagnostics, as rising zoonotic diseases and the use of artificial intelligence and machine learning increase demand for faster, more accurate testing solutions worldwide. This emphasis on advanced diagnostics underlines how Zoetis is tying its animal health portfolio more closely to data-driven tools that can improve clinical decision-making for both pets and livestock. We’ll now explore how Zoetis’s push...

If you are wondering whether Permian Resources is priced attractively today, or if the easy gains are already behind it, this article walks through the numbers so you can judge the value for yourself. The stock last closed at US$13.50, with a 3.8% decline over the past week, an 8.7% decline over the past month, and a 6.2% decline year to date, while the 3 year return stands at 65.1% and the 5 year return is very large. Recent share price moves sit against a backdrop of ongoing interest in US...

Store closures put tariffs and profitability in focus for Carter's Carter's (CRI) recently outlined plans to close between 100 and 150 low margin or underperforming stores by 2026, citing tariffs as a key factor. This has put its brick and mortar footprint and approach to profitability under closer investor scrutiny. See our latest analysis for Carter's. Carter's recent store closure plan has landed in a mixed share price backdrop, with a 90 day share price return of 17.2% and a 1 year total...

Ferrari stock performance snapshot Ferrari (RACE) has drawn attention after recent share price weakness, with the stock closing at US$366.81 and showing negative returns over the past week, month, past 3 months and year. See our latest analysis for Ferrari. That recent share price softness comes after a weaker patch over several months, with a 1 year total shareholder return of 14.8% decline sitting against a still sizeable 60.3% gain over three years and 71.0% over five years. This suggests...